ResearcherConsejo Nacional de Investigaciones Científicas y TécnicasActive in the last 2 years

Laura Cecilia Laurella

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-0378-0737; OpenAlex author ID A5022037217. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

In Vitro Evaluation of Natural Sesquiterpene Lactones and Naphthoquinones Against Pancreatic Ductal Adenocarcinoma Cells. Co-author DOI 10.3390/molecules31061014 ↗
Sesquiterpene Lactones as Promising Candidates for Cancer Therapy: Focus on Pancreatic Cancer. Co-author DOI 10.3390/molecules27113492 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Nadia Talin Mirakian · 2 shared papers, 2022–2026 · strength 0.45
- Paper In Vitro Evaluation of Natural Sesquiterpene Lactones and Naphthoquinones Against Pancreatic Ductal Adenocarcinoma Cell… DOI 10.3390/molecules31061014 ↗
- Paper Sesquiterpene Lactones as Promising Candidates for Cancer Therapy: Focus on Pancreatic Cancer. DOI 10.3390/molecules27113492 ↗
Daniela Laura Papademetrio · 2 shared papers, 2022–2026 · strength 0.45
- Paper In Vitro Evaluation of Natural Sesquiterpene Lactones and Naphthoquinones Against Pancreatic Ductal Adenocarcinoma Cell… DOI 10.3390/molecules31061014 ↗
- Paper Sesquiterpene Lactones as Promising Candidates for Cancer Therapy: Focus on Pancreatic Cancer. DOI 10.3390/molecules27113492 ↗
María Noé Garcia · 1 shared paper, 2022 · strength 0.19
- Paper Sesquiterpene Lactones as Promising Candidates for Cancer Therapy: Focus on Pancreatic Cancer. DOI 10.3390/molecules27113492 ↗
Daniel Grasso · 1 shared paper, 2022 · strength 0.19
- Paper Sesquiterpene Lactones as Promising Candidates for Cancer Therapy: Focus on Pancreatic Cancer. DOI 10.3390/molecules27113492 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.